Nifty
:
24270.85
Sensex
:
77763.91
95.15 (0.39%)
261.79 (0.34%)
Nifty
Sensex
:
:
24270.85
77763.91
95.15 (0.39%)
261.79 (0.34%)

Zim Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
56/99

BSE: 541400 | NSE: ZIMLAB

NSE BSE
122.01
03-Jul-2026
  • Open
  • High
  • Low
  • Previous Close
  •  124.5
  •  124.5
  •  122.01
  •  124.50
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  18310
  •  2268895.08
  •  133.9
  •  59.31

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 658.65
  • 112.82
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 738.06
  • N/A
  • 2.24

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 30.35%
  • 17.06%
  • 32.77%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 19.82%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 4.77
  • 2.34
  • 0.63

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.48
  • -6.04
  • -6.20

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -10.93
  • -16.69
  • -30.30

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.55
  • 30.68
  • 32.01

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.67
  • 1.97
  • 2.05

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.29
  • 10.71
  • 12.07

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Net Sales
105.27
108.73
-3.18%
108.66
96.33
12.80%
88.71
92.14
-3.72%
71.76
81.82
-12.30%
Expenses
98.08
94.14
4.19%
95.85
84.77
13.07%
82.96
82.61
0.42%
67.50
73.79
-8.52%
EBITDA
7.19
14.60
-50.75%
12.80
11.56
10.73%
5.75
9.53
-39.66%
4.26
8.04
-47.01%
EBIDTM
6.83%
13.42%
11.78%
12.00%
6.49%
10.34%
5.94%
9.82%
Other Income
6.16
1.71
260.23%
1.70
1.76
-3.41%
2.04
1.32
54.55%
1.48
1.00
48.00%
Interest
3.31
2.91
13.75%
3.43
2.73
25.64%
3.16
2.89
9.34%
3.30
2.86
15.38%
Depreciation
5.10
5.29
-3.59%
5.03
4.88
3.07%
4.98
5.00
-0.40%
4.86
4.94
-1.62%
PBT
4.94
8.11
-39.09%
6.05
5.70
6.14%
-0.34
2.96
-
-2.43
1.23
-
Tax
1.20
3.22
-62.73%
1.65
1.70
-2.94%
0.08
0.58
-86.21%
-0.56
0.34
-
PAT
3.74
4.88
-23.36%
4.40
4.00
10.00%
-0.42
2.38
-
-1.88
0.90
-
PATM
3.55%
4.49%
4.05%
4.15%
-0.48%
2.58%
-2.61%
1.10%
EPS
0.70
1.00
-30.00%
0.90
0.82
9.76%
-0.09
0.49
-
-0.38
0.18
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
374.40
379.03
367.42
398.53
333.43
307.26
277.74
335.37
272.80
235.01
Net Sales Growth
-
-1.22%
3.16%
-7.81%
19.52%
8.52%
10.63%
-17.18%
22.94%
16.08%
 
Cost Of Goods Sold
-
165.38
167.85
171.44
198.83
160.35
158.63
143.14
159.51
140.89
119.96
Gross Profit
-
209.03
211.18
195.98
199.69
173.08
148.63
134.60
175.86
131.91
115.04
GP Margin
-
55.83%
55.72%
53.34%
50.11%
51.91%
48.37%
48.46%
52.44%
48.35%
48.95%
Total Expenditure
-
344.39
335.30
326.09
346.54
292.45
267.50
255.13
293.34
238.02
203.53
Power & Fuel Cost
-
18.17
17.39
13.47
11.09
9.14
7.04
7.47
7.19
5.75
5.35
% Of Sales
-
4.85%
4.59%
3.67%
2.78%
2.74%
2.29%
2.69%
2.14%
2.11%
2.28%
Employee Cost
-
63.90
60.76
53.34
49.32
40.07
35.76
35.35
48.26
40.80
33.00
% Of Sales
-
17.07%
16.03%
14.52%
12.38%
12.02%
11.64%
12.73%
14.39%
14.96%
14.04%
Manufacturing Exp.
-
44.35
38.37
39.34
33.83
29.03
23.40
26.97
13.62
7.82
7.76
% Of Sales
-
11.85%
10.12%
10.71%
8.49%
8.71%
7.62%
9.71%
4.06%
2.87%
3.30%
General & Admin Exp.
-
22.85
20.21
17.98
19.55
15.82
10.72
11.61
14.53
10.85
10.30
% Of Sales
-
6.10%
5.33%
4.89%
4.91%
4.74%
3.49%
4.18%
4.33%
3.98%
4.38%
Selling & Distn. Exp.
-
24.51
24.12
24.48
27.94
32.70
27.96
24.51
45.61
28.22
22.53
% Of Sales
-
6.55%
6.36%
6.66%
7.01%
9.81%
9.10%
8.82%
13.60%
10.34%
9.59%
Miscellaneous Exp.
-
5.22
6.61
6.04
5.98
5.35
3.98
6.07
4.62
3.69
22.53
% Of Sales
-
1.39%
1.74%
1.64%
1.50%
1.60%
1.30%
2.19%
1.38%
1.35%
1.97%
EBITDA
-
30.01
43.73
41.33
51.99
40.98
39.76
22.61
42.03
34.78
31.48
EBITDA Margin
-
8.02%
11.54%
11.25%
13.05%
12.29%
12.94%
8.14%
12.53%
12.75%
13.40%
Other Income
-
11.38
5.78
5.18
6.41
4.40
2.34
4.52
2.05
3.42
5.51
Interest
-
13.20
11.39
6.92
5.58
8.31
10.90
12.65
10.59
9.34
10.47
Depreciation
-
19.98
20.11
15.95
17.47
16.03
15.79
14.41
11.42
9.79
9.02
PBT
-
8.21
18.01
23.64
35.35
21.04
15.41
0.07
22.07
19.07
17.50
Tax
-
2.37
5.84
6.40
10.92
6.49
2.91
-3.23
6.73
5.83
-1.09
Tax Rate
-
28.87%
32.43%
27.07%
30.89%
30.85%
28.45%
-4614.29%
30.49%
23.39%
-6.23%
PAT
-
5.84
12.16
17.25
24.43
14.55
7.32
3.30
15.34
19.11
18.59
PAT before Minority Interest
-
5.84
12.16
17.25
24.43
14.55
7.32
3.30
15.34
19.11
18.59
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
1.56%
3.21%
4.69%
6.13%
4.36%
2.38%
1.19%
4.57%
7.01%
7.91%
PAT Growth
-
-51.97%
-29.51%
-29.39%
67.90%
98.77%
121.82%
-78.49%
-19.73%
2.80%
 
EPS
-
1.09
2.27
3.22
4.57
2.72
1.37
0.62
2.87
3.57
3.47

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
296.15
252.24
238.75
200.35
175.71
160.75
153.82
151.12
136.60
118.33
Share Capital
53.50
48.73
48.73
48.73
16.24
16.24
16.18
16.12
8.06
8.03
Total Reserves
240.22
202.16
190.02
151.62
159.47
144.51
137.28
133.77
127.95
109.59
Non-Current Liabilities
52.38
53.42
48.65
30.45
20.01
19.40
22.72
20.19
16.61
18.09
Secured Loans
41.59
40.30
35.60
24.62
18.92
21.83
27.01
19.14
15.91
26.75
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.41
3.02
4.37
0.77
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.01
0.00
0.10
0.00
0.00
Current Liabilities
191.22
167.56
159.43
110.79
147.37
142.04
143.44
156.40
141.40
113.21
Trade Payables
72.93
69.51
62.38
58.24
81.07
64.87
66.00
71.95
66.26
45.05
Other Current Liabilities
51.90
40.80
41.21
29.07
44.71
31.16
26.68
38.65
25.15
18.33
Short Term Borrowings
62.13
52.46
55.04
22.88
17.34
44.60
49.69
40.15
49.56
46.70
Short Term Provisions
4.26
4.79
0.80
0.59
4.24
1.40
1.06
5.65
0.43
3.14
Total Liabilities
539.75
473.22
446.83
341.59
343.09
322.19
319.98
327.71
294.61
249.63
Net Block
161.78
164.28
160.83
108.66
105.64
106.52
115.92
106.01
94.16
88.75
Gross Block
290.02
274.88
266.57
198.66
180.24
165.49
159.23
135.67
112.90
97.77
Accumulated Depreciation
128.23
110.61
105.74
90.01
74.60
58.97
43.31
29.66
18.74
9.02
Non Current Assets
263.12
240.72
219.17
150.63
129.49
130.43
137.94
132.39
121.68
95.86
Capital Work in Progress
95.53
70.46
42.28
26.99
11.74
10.68
9.62
13.32
8.29
3.82
Non Current Investment
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
0.05
Long Term Loans & Adv.
5.47
5.42
15.71
14.41
11.78
11.32
10.40
11.72
18.05
3.07
Other Non Current Assets
0.29
0.51
0.31
0.52
0.28
1.85
1.95
1.29
1.13
0.16
Current Assets
276.63
232.50
227.65
190.95
213.59
191.76
182.03
195.32
172.94
153.77
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
93.77
86.47
81.26
53.71
75.28
54.35
56.39
55.05
51.56
35.47
Sundry Debtors
109.04
106.92
100.17
95.25
89.52
72.25
67.93
93.10
89.22
88.18
Cash & Bank
43.41
2.49
10.46
7.52
4.97
8.35
3.95
2.94
3.53
5.61
Other Current Assets
30.41
3.03
2.29
2.56
43.82
56.81
53.76
44.23
28.63
24.52
Short Term Loans & Adv.
27.14
33.59
33.46
31.91
42.41
55.26
52.16
42.83
27.51
23.51
Net Current Assets
85.42
64.94
68.22
80.16
66.23
49.72
38.60
38.92
31.54
40.56
Total Assets
539.75
473.22
446.82
341.58
343.08
322.19
319.97
327.71
294.62
249.63

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
49.53
41.15
16.28
38.17
49.21
31.85
21.92
34.94
36.68
32.07
PBT
8.21
18.01
23.64
35.35
21.04
15.41
0.07
22.07
24.94
17.50
Adjustment
29.10
33.64
22.01
22.16
22.01
25.79
26.25
23.82
12.84
20.78
Changes in Working Capital
15.96
-11.57
-26.79
-12.19
6.58
-8.24
0.56
-9.64
2.96
-3.72
Cash after chg. in Working capital
53.27
40.08
18.86
45.32
49.64
32.96
26.87
36.25
40.73
34.56
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.73
1.08
-2.58
-7.15
-0.43
-1.11
-4.96
-1.31
-4.06
-2.49
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-56.35
-39.93
-73.01
-36.20
-14.57
-5.88
-19.41
-20.68
-25.83
-7.24
Net Fixed Assets
-37.27
-33.16
-81.96
-32.76
-15.55
-7.23
-19.28
-22.29
-19.60
21.70
Net Investments
-4.62
-4.81
-0.05
0.00
-0.10
0.00
-3.54
-4.45
0.00
0.00
Others
-14.46
-1.96
9.00
-3.44
1.08
1.35
3.41
6.06
-6.23
-28.94
Cash from Financing Activity
28.19
-9.10
59.53
0.55
-32.97
-25.97
-2.16
-15.16
-9.80
-25.15
Net Cash Inflow / Outflow
21.37
-7.88
2.80
2.51
1.66
0.00
0.35
-0.90
1.04
-0.32
Opening Cash & Equivalents
1.95
9.60
6.42
3.42
1.39
1.46
0.50
1.47
0.42
0.74
Closing Cash & Equivalent
25.12
1.95
9.60
6.42
3.42
1.39
1.46
0.50
1.47
0.42

Financial Ratios

Consolidated /

Standalone
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
54.90
51.49
49.00
41.12
36.06
32.99
94.84
92.99
84.38
73.25
ROA
1.15%
2.64%
4.38%
7.14%
4.37%
2.28%
1.02%
4.93%
7.02%
7.33%
ROE
2.14%
4.97%
7.86%
13.00%
8.65%
4.66%
2.17%
10.73%
15.07%
17.21%
ROCE
5.47%
8.29%
10.11%
16.82%
12.52%
8.70%
5.39%
14.64%
16.46%
14.20%
Fixed Asset Turnover
1.33
1.40
1.58
2.10
1.93
1.89
1.88
2.70
2.60
2.21
Receivable days
105.27
99.71
97.06
84.61
88.55
83.26
105.81
99.21
118.05
133.84
Inventory Days
87.86
80.76
67.04
59.07
70.95
65.77
73.23
58.02
57.91
55.43
Payable days
157.18
143.40
128.40
127.86
166.10
150.56
175.89
88.19
86.92
85.73
Cash Conversion Cycle
35.94
37.07
35.70
15.82
-6.61
-1.53
3.15
69.04
89.04
103.54
Total Debt/Equity
0.42
0.45
0.44
0.30
0.29
0.50
0.59
0.52
0.60
0.68
Interest Cover
1.62
2.58
4.41
7.34
3.53
1.94
1.01
3.08
3.67
2.67

Annual Reports:

FY 2026
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • ZIM Laboratories secures marketing authorization for ‘Dabigatran Etexilate’ in Italy
    20th May 2026, 10:11 AM

    This authorisation will facilitate faster approvals in other European Union countries as well as the UK

    Read More
  • Zim Laboratories - Quarterly Results
    20th May 2026, 00:00 AM

    Read More
  • ZIM Laboratories invests Rs 89.45 lakh in ZIMTAS
    9th Apr 2026, 15:42 PM

    Post investment, the company holds 99.96% of the total share capital of ZIMTAS

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.